The biotech industry is fueled by biopharmaceutical companies' growing adoption of advanced technologies and a growing focus on developing personalized medicines. Given the industry’s steady growth prospects, investors could consider quality biotech stocks Halozyme Therapeutics, Inc. (HALO), BioMarin Pharmaceutical Inc. (BMRN), and United Therapeutics Corporation (UTHR).
The expansion of healthcare infrastructure in emerging countries is accompanied by rapid growth of healthcare facilities and modernization. This aspect contributes to diagnostic laboratories’ increasing demand for clinical diagnostic procedures, leading to higher sales and revenue growth of biotechnologies in the market.
